NOVOCURE LTD (NVCR)
JE00BYSS4X48 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -149.79M | -207.04M | -92.53M | -58.35M | 19.81M | |||
| Depreciation Amortization | 10.85M | 10.97M | 10.62M | 10.25M | 9.15M | |||
| Change In Working Capital | 13.33M | 29.56M | 9.58M | 28.98M | -8.52M | |||
| Interest Paid | 4.94M | 6.00K | 40.00K | 100.00K | 8.69M | |||
| Taxes Paid | 21.97M | 13.66M | 5.48M | 3.11M | -3.26M | |||
| Other non cash items | 88.12M | 93.18M | 103.12M | 101.88M | 78.71M | |||
| OPERATING CASH FLOW | -37.47M | -73.34M | 30.79M | 82.76M | 99.15M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -40.74M | -27.09M | -21.36M | -24.17M | -14.97M | |||
| Other Investing Activity | 21.20M | 211.24M | -118.60M | -120.66M | -457.88M | |||
| INVESTING CASH FLOW | -19.53M | 184.15M | -139.96M | -144.83M | -472.85M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 84.01M | -10.00K | -30.00K | -30.00K | 408.41M | |||
| Stock Issued/Repurchased | 5.53M | 15.80M | 15.52M | 25.73M | 31.80M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 89.54M | 15.79M | 15.49M | 25.70M | 440.21M | |||
| Exchange Rate Effect | 155.00K | 131.00K | -100.00K | -190.00K | 250.00K | |||
| CHANGE IN CASH | 32.68M | 126.73M | -93.78M | -36.56M | 66.76M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -37.47M | -73.34M | 30.79M | 82.76M | 99.15M | |||
| Capital Expenditure | -40.74M | -27.09M | -21.36M | -24.17M | -14.97M | |||
| FREE CASH FLOW | -78.21M | -100.43M | 9.43M | 58.59M | 84.18M | |||
All data in USD